|
US4278681A
(en)
|
1979-03-12 |
1981-07-14 |
Warner-Lambert Co. |
Antibacterial amide compounds and means for using the same
|
|
US4311698A
(en)
|
1979-03-12 |
1982-01-19 |
Haskell Theodore H |
Aminoacid derivatives of cephalosporin compounds
|
|
JPS56115784A
(en)
|
1980-02-15 |
1981-09-11 |
Tanabe Seiyaku Co Ltd |
Novel pyridinecarboxamide derivative and its preparation
|
|
US4315858A
(en)
|
1980-09-24 |
1982-02-16 |
Warner-Lambert Company |
Antibacterial amide compounds
|
|
US4315014A
(en)
|
1980-09-24 |
1982-02-09 |
Warner-Lambert Company |
Antibacterial amide compounds and pharmaceutical composition containing the same
|
|
JPH02127429A
(ja)
|
1988-11-07 |
1990-05-16 |
Motoo Takayanagi |
ピラジン環含有芳香族ポリアミドおよびその製造法
|
|
JPH02127512A
(ja)
|
1988-11-07 |
1990-05-16 |
Motoo Takayanagi |
ピラジン環含有芳香族ポリアミド繊維
|
|
GB2273930A
(en)
*
|
1992-12-30 |
1994-07-06 |
Glaxo Group Ltd |
Benzanilide derivatives
|
|
US5563143A
(en)
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
|
DE19624668A1
(de)
|
1996-06-20 |
1998-02-19 |
Klinge Co Chem Pharm Fab |
Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden
|
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
JP3354090B2
(ja)
|
1996-09-30 |
2002-12-09 |
シエーリング アクチエンゲゼルシャフト |
分化誘導剤
|
|
JP4405602B2
(ja)
|
1998-04-16 |
2010-01-27 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ヒストン脱アセチル化酵素阻害剤
|
|
JP2000256194A
(ja)
|
1999-01-06 |
2000-09-19 |
Mitsui Chemicals Inc |
核内レセプタ作動薬およびその効果増強剤
|
|
CN1209016C
(zh)
|
1999-08-18 |
2005-07-06 |
阿方蒂农科有限公司 |
杀真菌剂
|
|
IL156413A0
(en)
*
|
2001-01-31 |
2004-01-04 |
Pfizer Prod Inc |
Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
|
|
WO2003003008A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Chemical libraries useful for drug discovery processes
|
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
|
WO2003055477A1
(en)
|
2001-12-21 |
2003-07-10 |
7Tm Pharma A/S |
Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
|
|
DE60320933D1
(de)
|
2002-01-10 |
2008-06-26 |
Bayer Healthcare Ag |
Rho-kinase inhibitoren
|
|
EP1348434A1
(en)
|
2002-03-27 |
2003-10-01 |
Fujisawa Deutschland GmbH |
Use of pyridyl amides as inhibitors of angiogenesis
|
|
AU2003292888A1
(en)
|
2002-12-27 |
2004-07-22 |
Schering Aktiengesellschaft |
Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
|
|
DE10334724A1
(de)
|
2003-07-30 |
2005-02-24 |
Bayer Healthcare Ag |
N-Biarylamide
|
|
US20060063930A1
(en)
|
2004-08-20 |
2006-03-23 |
Agoston Gregory E |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
DK1789390T3
(da)
|
2004-09-02 |
2012-02-27 |
Genentech Inc |
Pyridyl-inhibitorer af hedgehog-signalering
|
|
UY29300A1
(es)
|
2004-12-22 |
2006-07-31 |
Astrazeneca Ab |
Compuestos quimicos
|
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
|
WO2007024922A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
WO2007062028A2
(en)
|
2005-11-21 |
2007-05-31 |
Tap Pharmaceutical Products, Inc. |
Treatment of qt interval prolongation and diseases associated therewith
|
|
TWI372752B
(en)
|
2005-12-22 |
2012-09-21 |
Nihon Nohyaku Co Ltd |
Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
|
|
WO2007076055A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
CA2856037C
(en)
*
|
2005-12-28 |
2017-03-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
WO2007125331A2
(en)
|
2006-04-26 |
2007-11-08 |
Cancer Research Technology Limited |
Amino-ethyl-amino-aryl (aeaa) compounds and their use
|
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
|
FR2904827B1
(fr)
|
2006-08-11 |
2008-09-19 |
Sanofi Aventis Sa |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii
|
|
US20080076800A1
(en)
|
2006-08-24 |
2008-03-27 |
Huang Kenneth H |
Benzene, Pyridine, and Pyridazine Derivatives
|
|
WO2008026018A1
(en)
|
2006-09-01 |
2008-03-06 |
Topotarget Switzerland Sa |
New method for the treatment of inflammatory diseases
|
|
FR2921657A1
(fr)
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
|
US8324226B2
(en)
|
2007-10-24 |
2012-12-04 |
Cancer Research Technology Limited |
Therapeutic oxy-phenyl-aryl compounds and their use
|
|
US8664396B2
(en)
|
2007-11-21 |
2014-03-04 |
Bio-Rad Laboratories, Inc. |
Photoluminescent metal complexes for protein staining
|
|
MX365732B
(es)
|
2007-12-07 |
2019-06-12 |
Vertex Pharma |
Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos.
|
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
|
EP2098231A1
(en)
|
2008-03-05 |
2009-09-09 |
Topotarget Switzerland SA |
Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury
|
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
MX2012004792A
(es)
*
|
2009-10-22 |
2013-02-01 |
Vertex Pharma |
Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
|
|
UY33469A
(es)
*
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
JP2013530199A
(ja)
|
2010-07-06 |
2013-07-25 |
ノバルティス アーゲー |
キナーゼ阻害剤として有用な環状エーテル化合物
|
|
WO2012006475A1
(en)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
JP5823514B2
(ja)
|
2010-07-07 |
2015-11-25 |
アーデリクス，インコーポレーテッド |
リン酸輸送を阻害する化合物及び方法
|
|
PT2599771T
(pt)
|
2010-07-30 |
2016-12-14 |
Univ Kyoto |
Derivado de naftaleno
|
|
WO2012024179A1
(en)
|
2010-08-18 |
2012-02-23 |
Merck Sharp & Dohme Corp. |
Substituted amide derivatives as dgat-1 inhibitors
|
|
PE20140011A1
(es)
|
2010-09-03 |
2014-01-31 |
Forma Tm Llc |
Compuestos y composiciones novedosos para la inhibicion de nampt
|
|
ES2574832T3
(es)
|
2010-09-30 |
2016-06-22 |
Kyoto University |
Agente para el tratamiento de enfermedades oculares
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
|
JP6215194B2
(ja)
|
2011-05-16 |
2017-10-18 |
コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． |
生体直交型薬物活性化
|
|
CA2877474A1
(en)
|
2011-06-20 |
2012-12-27 |
Myrexis, Inc. |
Compounds and therapeutic uses thereof
|
|
WO2013028445A1
(en)
*
|
2011-08-19 |
2013-02-28 |
Glaxosmithkline Llc |
Fatty acid synthase inhibitors
|
|
EP2589292A1
(en)
|
2011-11-02 |
2013-05-08 |
Bayer CropScience AG |
Compounds with nematicidal activity
|
|
WO2013064460A1
(en)
|
2011-11-02 |
2013-05-10 |
Bayer Intellectual Property Gmbh |
Compounds with nematicidal activity
|
|
GB201120993D0
(en)
|
2011-12-06 |
2012-01-18 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
WO2014008214A1
(en)
|
2012-07-02 |
2014-01-09 |
Biogen Idec Ma Inc. |
Biaryl-containing compounds as inverse agonists of ror-gamma receptors
|
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
|
WO2014081303A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
|
JP5799117B2
(ja)
|
2013-02-05 |
2015-10-21 |
大日本住友製薬株式会社 |
ウラシル誘導体からなる医薬
|
|
DK2988743T3
(da)
|
2013-03-15 |
2021-03-01 |
Epigen Biosciences Inc |
Heterocykliske forbindelser, der kan anvendes til behandling af sygdom
|
|
US20160046616A1
(en)
*
|
2013-03-15 |
2016-02-18 |
The Johns Hopkins University |
Nrf2 small molecule inhibitors for cancer therapy
|
|
EP3010586A1
(en)
*
|
2013-06-21 |
2016-04-27 |
Lupin Limited |
Substituted heterocyclic compounds as crac modulators
|
|
GB201316823D0
(en)
*
|
2013-09-23 |
2013-11-06 |
R & D Vernalis Ltd |
New Chemical Entities
|
|
CA2936865A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
KR102265277B1
(ko)
|
2014-04-11 |
2021-06-16 |
판옵테스 파르마 게스.엠.베.하. |
바이러스 억제 화합물로서의 항-염증제
|
|
TW201625641A
(zh)
|
2014-05-22 |
2016-07-16 |
健臻公司 |
Ｎａｍｐｔ抑制劑及方法
|
|
US10669234B2
(en)
*
|
2015-07-14 |
2020-06-02 |
Mission Therapeutics Limited |
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
|
|
EP3389781B1
(en)
*
|
2015-12-15 |
2021-08-11 |
University of Miami |
Inhibitors of tnf superfamily costimulatory interactions and methods for uses of the same
|
|
GB201602854D0
(en)
*
|
2016-02-18 |
2016-04-06 |
Mission Therapeutics Ltd |
Novel compounds
|
|
CN108713013B
(zh)
|
2016-02-29 |
2021-06-18 |
住友化学株式会社 |
杂环化合物
|
|
US11078195B2
(en)
|
2016-03-17 |
2021-08-03 |
Checkmate Therapeutics Inc. |
Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
|
|
US10398783B2
(en)
|
2016-10-20 |
2019-09-03 |
Bristol-Myers Squibb Company |
Antiproliferative compounds and conjugates made therefrom
|
|
JP6991997B2
(ja)
|
2016-12-01 |
2022-01-13 |
住友化学株式会社 |
複素環化合物及びそれを含有する有害節足動物防除組成物
|
|
CN108314677B
(zh)
|
2017-01-17 |
2020-06-30 |
安徽中科拓苒药物科学研究有限公司 |
一种ezh2抑制剂及其用途
|
|
AU2018251415B2
(en)
|
2017-04-11 |
2021-08-05 |
Mitsui Chemicals Crop & Life Solutions, Inc. |
Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients
|
|
WO2018216640A1
(ja)
|
2017-05-22 |
2018-11-29 |
小野薬品工業株式会社 |
Ｅｐ４アンタゴニスト
|
|
AU2019212959A1
(en)
|
2018-01-29 |
2020-09-17 |
Capulus Therapeutics, Llc |
SREBP inhibitors comprising a 6-membered central ring
|
|
KR102831570B1
(ko)
|
2018-05-04 |
2025-07-10 |
레미디 플랜, 인크. |
암 줄기 세포를 표적화하는 암 치료
|
|
JP7399589B2
(ja)
|
2018-09-12 |
2023-12-18 |
日本化薬株式会社 |
有害生物防除剤
|
|
AU2020378067A1
(en)
|
2019-11-06 |
2022-05-26 |
Remedy Plan, Inc. |
Cancer treatments targeting cancer stem cells
|
|
KR102210267B1
(ko)
|
2020-05-26 |
2021-02-01 |
(주)피엔에이치테크 |
유기발광 화합물 및 이를 포함하는 유기발광소자
|
|
WO2022050286A1
(ja)
|
2020-09-02 |
2022-03-10 |
国立大学法人東京大学 |
有機半導体材料
|
|
JP2024518089A
(ja)
|
2021-05-13 |
2024-04-24 |
リメディー プラン，インコーポレーテッド |
Ｎａｍｐｔ阻害剤とその使用
|